Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis

BACKGROUND: The dexamethasone 0.4mg intracanalicular insert (Dextenza, Ocular Therapeutix, Bedford, MA) is approved for control of postoperative pain and inflammation following ocular surgery. This study compared pain and inflammation resolution following phacoemulsification in eyes that received th...

Ausführliche Beschreibung

Bibliographische Detailangaben
1. Verfasser: Foster, Brian
Format: Online Artikel Text
Sprache:English
Veröffentlicht: Dove 2021
Schlagworte:
Original Research
Online Zugang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541700/
https://www.ncbi.nlm.nih.gov/pubmed/34703199
http://dx.doi.org/10.2147/OPTH.S335764

Online

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541700/
https://www.ncbi.nlm.nih.gov/pubmed/34703199
http://dx.doi.org/10.2147/OPTH.S335764

Ähnliche Einträge